CRON Cronos Group Inc.
USHealthcareAs of 2026-08-24
Why CRON matters now
Cronos Group Inc. (CRON) is a US stock in Healthcare. The latest InvestLog snapshot shows $3.41 with +3.02% on the session and $1.27B in market capitalization; recent performance reads 1-month +3.83% and YTD +3.04%.
The latest financial table shown here is Q1 2026, with revenue of $44.6M, net income of $13.6M, and EPS of $0.04. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.6%.
The latest indexable market news headline is "4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $2.30; recent insider activity includes Kenost Jared Matthew filing F-InKind. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.95
P/S
6.30
EV/EBITDA
3.85
DCF Value
$-6.73
FCF Yield
2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
42.2%
Operating Margin
-7.8%
Net Margin
-1.3%
ROE
-0.2%
ROA
-0.2%
ROIC
0.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $44.6M | $13.6M | $0.04 |
| Q4 2025 | $91.3M | $-1.8M | $-0.00 |
| FY 2025 | $193.4M | $-9.6M | $-0.02 |
| Q3 2025 | $36.3M | $26.0M | $0.07 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$2.30
Target (Median)
$2.30
Target Range
$2.30 - $2.30
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Exchange
—
Beta
1.25
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.